Day: March 16, 2022

Microcontroller Market to Reach USD 51.13 billion by 2028; Renesas Launched Ultra-Low Power, 32-bit RX140 Group of Microcontrollers (MCUs): Fortune Business Insights™

Written by Customer Service on March 16, 2022. Posted in Mergers And Acquisitions.

Companies in the Microcontroller Market are TOSHIBA ELECTRONIC DEVICES & STORAGE CORPORATION (Japan), Texas Instruments Incorporated (U.S.), Microchip Technology Inc. (U.S.), Renesas Electronics Corporation (Japan), STMicroelectronics (Switzerland), NXP Semiconductors (Netherlands), Intel (U.S.), Infineon Technologies AG (Germany), Maxim Integrated (Analog Devices), ON Semiconductor, ROHM CO., LTD. (Japan), Zilog, Inc. (U.S.) Pune, India, March 16, 2022 (GLOBE NEWSWIRE) — The Global Microcontroller Market size was valued at around USD 29.06 billion in 2020. The market is projected to rise from USD 30.63 billion in 2021 to USD 51.13 billion in 2028 at a CAGR of 7.6% during the forecast period 2021-2028. Fortune Business Insights™ has mentioned these insights in its latest research report, titled, “Microcontroller Market, 2021-2028.” According...

Formula Systems Reports Fourth Quarter and Full Year 2021 Financial Results with Annual Net Income of $54.6 Million

Written by Customer Service on March 16, 2022. Posted in Earnings Releases And Operating Results.

Record breaking revenues and operating income for the quarter and for the full year OR YEHUDA, Israel, March 16, 2022 (GLOBE NEWSWIRE) — Formula Systems (1985) Ltd. (NASDAQ: FORTY), a global information technology holding company engaged, through its subsidiaries and affiliates, in providing software consulting services and computer-based business solutions and developing proprietary software products, today announced its results for the fourth quarter and full year ended December 31, 2021. Financial Highlights for the Fourth Quarter Ended December 31, 2021Consolidated revenues for the fourth quarter ended December 31, 2021 increased by 21.3% to a record breaking $658.7 million, compared to $543.2 million in the same period last year. The growth was recorded across Formula’s entire investment portfolio.Consolidated operating...

Telos Corporation Announces Fourth Quarter Results: Delivers 43% Sales Growth and Expands Gross Margin 196 Basis Points; Issues 2022 Guidance

Written by Customer Service on March 16, 2022. Posted in Earnings Releases And Operating Results.

Increased Quarterly Revenue 43% to $64.1 Million; Driven by 37% Growth in Security Solutions and 49% Growth in Secure Networks Increased Quarterly Gross Profit 51% to $24.1 Million; Expanded Gross Margin 196 Basis Points to 37.7% Generated Full Year Cash Flow from Operations of $7.3 Million; a $9.4 Million Increase Over 2020ASHBURN, Va., March 16, 2022 (GLOBE NEWSWIRE) — Telos® Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced financial results for the fourth quarter and full year 2021. “We delivered reported revenue growth of 35%, 59% adjusted for the wind down of the 2020 Census program, notwithstanding customer delays on two large programs, and increased gross profit 38% during our first full year as a public...

Automotive Battery Market Size [2021-2028] Worth USD 65.62 Billion | Exhibit a CAGR 5.5%

Written by Customer Service on March 16, 2022. Posted in Mergers And Acquisitions.

Automotive Battery Market Size to Hit USD 65.62 billion, at CAGR of 5.5% by 2028; Ford to Form a Joint Venture with SK Innovation to Ramp Up North America Battery Deliveries Pune, India, March 16, 2022 (GLOBE NEWSWIRE) — The automotive battery market size was valued at around USD 43.32 billion in 2020. The market is projected to rise from USD 45.10 billion in 2021 to USD 65.62 billion by 2028 at 5.5% CAGR during the forecast period 2021-2028. Fortune Business Insights™ has mentioned these insights in its latest research report titled, “Automotive Battery Market, 2021-2028.” According to the study, soaring demand for automotive batteries along with the preference for battery-powered electric vehicles will provide lucrative growth opportunities. Besides, investments in electric vehicles (EVs) will complement the growth of e-mobility. Industry...

Electric Mobility Market Size [2021-2028] Worth USD 1,507.21 Billion | Exhibit a CAGR 27.2%

Written by Customer Service on March 16, 2022. Posted in Mergers And Acquisitions.

Electric Mobility Market Size to Hit USD 1,507.21 billion, at CAGR of 27.2% by 2028; Strong Government Support Toward Electric Vehicle Infrastructure Development to Fuel Growth Pune, India, March 16, 2022 (GLOBE NEWSWIRE) — The global electric mobility market size touched USD 230.12 billion in 2020. The market is expected to grow from USD 279.45 billion in 2021 to USD 1,507.21 billion in 2028, exhibiting a CAGR of 27.2% during the forecast period. Rising automotive electrification and adoption of electric micro-mobility are expected to foster market growth. Fortune Business Insights™ presents this information in its report titled “Electric Mobility Market, 2021-2028.” Electric mobility is the adoption of e-bikes, cars, and motorbikes to reduce environmental impact. Rising automotive electrification is expected to boost the adoption...

Automotive E-axle Market Size to Hit USD 65.73 Billion by 2028 | Exhibit a CAGR of 31.4%

Written by Customer Service on March 16, 2022. Posted in Mergers And Acquisitions.

Automotive E-axle Market to Grow at a CAGR of 31.4% in 2021-2028; Implementation of Decarbonization Strategies to Drive Market Pune, India, March 16, 2022 (GLOBE NEWSWIRE) — The Global Automotive E-axle market size to rise from USD 9.71 billion in 2021 to USD 65.73 billion by 2028 at a CAGR of 31.4% during the forecast period. The global Automotive E-axle market size was USD 7.21 billion in 2020. Automotive e-axle refers to a compact electric drive solution that combines the transmission, electric motor, and power electronics into a single unit. This single casing allows for simple integration of several components, a single cooling system for all parts, streamlined packaging, and improved efficiency. The increasing development in electronic vehicles is likely to boost the market growth during forecast period. Rising Electrical...

Nuclear Medicine Market Size [2022-2028] worth USD 19.47 Billion | exhibiting a CAGR of 19.6%

Written by Customer Service on March 16, 2022. Posted in Mergers And Acquisitions.

The global nuclear medicine market size was USD 5.04 billion in 2020. The market is projected to grow from USD 5.57 billion in 2021 to USD 19.47 billion by 2028 at a CAGR of 19.6% during the 2022-2028 period. Pune, India, March 16, 2022 (GLOBE NEWSWIRE) — The global nuclear medicine market size was USD 5.04 billion in 2020. The market is projected to grow from USD 5.57 billion in 2021 to USD 19.47 billion by 2028 at a CAGR of 19.6% during the 2022-2028 period. This information is provided by Fortune Business Insights™, in its report, titled, “Nuclear Medicine Market, 2022-2028.” According to our researchers, the market growth is primarily accredited to the rising occurrence of chronic conditions. Furthermore, technological progressions empowering the usage of radiopharmaceuticals to analyze and treat cancerous tumors aid towards...

Lands’ End Announces Full Year and Fourth Quarter Fiscal 2021 Results

Written by Customer Service on March 16, 2022. Posted in Earnings Releases And Operating Results.

Net Revenue grew 14.7% compared to full year Fiscal 2020, delivering highest revenue since 2011Net Income of $33.4 million compared to Net Income of $10.8 million for full year Fiscal 2020Adjusted EBITDA of $120.9 million compared to Adjusted EBITDA of $87.0 million for full year Fiscal 2020, delivering highest Adjusted EBITDA since 2014Initiates Fiscal 2022 Outlook DODGEVILLE, Wis., March 16, 2022 (GLOBE NEWSWIRE) — Lands’ End, Inc. (NASDAQ: LE) today announced financial results for the full year and fourth quarter of the fiscal year ended January 28, 2022 compared to the full year and fourth quarter of the fiscal year ended January 29, 2021, and provided first quarter and full year fiscal 2022 outlook. Jerome Griffith, Chief Executive Officer, stated, “Over the past year, we continued to demonstrate the strength of our business...

Porch Group Reports Fourth Quarter and Full Year 2021 Audited Financial Results

Written by Customer Service on March 16, 2022. Posted in Earnings Releases And Operating Results.

– Filed Annual Report on Form 10-K on March 16, 2022 – – Reports $192.4 Million of Full Year 2021 Revenue, up 166% Year-Over-Year – – Reiterates 2022 Guidance Provided on March 1, 2022 – SEATTLE, March 16, 2022 (GLOBE NEWSWIRE) — Porch Group, Inc. (“Porch” or “the Company”) (NASDAQ: PRCH), a leading vertical software company reinventing the home services and insurance industries, today filed its Annual Report on Form 10-K and reported audited financial results for the fourth quarter and full year ended December 31, 2021. On March 1, 2022, the Company announced unaudited results for the fourth quarter and full year ended December 31, 2021. This press release updates and supersedes the press release issued on March 1, 2022 to reflect two adjustments to the Company’s financial results as a result...

Junshi Biosciences Announces First Patient Dosed in China in Phase III Clinical Trial of VV116 in Treatment of Moderate to Severe COVID-19

Written by Customer Service on March 16, 2022. Posted in Public Companies.

SHANGHAI, China, March 16, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the first patient was dosed in its Phase III trial of VV116 for the treatment of moderate to severe COVID-19. The study is an international multicenter, randomized, double-blind, controlled Phase III study to evaluate the efficacy and safety of VV116 against standard therapy in subjects with moderate to severe COVID-19. The primary endpoint is the percentage of patients who progress to critical/severe COVID-19 patients or all-cause mortality within 29 days. VV116 is an oral nucleoside analog anti-SARS-CoV-2 investigational drug jointly developed...

Day: March 16, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals